Fresh Tracks Therapeutics, Inc. Profile Avatar - Palmy Investing

Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company dev…

Biotechnology
US, Boulder [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Fresh Tracks Therapeutics, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of FRTX's Analysis
CIK: 819050 CUSIP: - ISIN: US10802T2042 LEI: - UEI: -
Secondary Listings
FRTX has no secondary listings inside our databases.